Portage Biotech Inc. Reports Asset and Liability Changes

TipRanksNov 27 05:48

Portage Biotech Reports Reduced Losses and Strategic Plans

TipRanksNov 27 05:48

Express News | Portage Biotech: Adport-601 Trial Is Paused for Further Patient Accrual Pending Additional Financial Resources

BreakingsNov 27 05:27

Express News | Portage Biotech: Continuing to Explore Multiple Strategic Alternatives

BreakingsNov 27 05:26

Portage Biotech 2Q Loss/Shr $1.26 >PRTG

Dow JonesNov 27 05:08

Express News | Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

BreakingsNov 27 05:05